Cooley Achieves Recognitions in US, Global M&A and PE Rankings

New York – July 15, 2024 – Cooley’s global mergers and acquisitions practice has been recognized based on its M&A activity on multiple midyear league tables, including Bloomberg, Mergermarket, and LSEG Data & Analytics (formerly known as Refinitiv). Despite what remains an unsettled market, Cooley’s M&A and private equity practice continues to excel in public and private transactions in the US and globally.

Cooley’s rankings include:

• Bloomberg, which ranked the firm #3 for global and US-announced deals by deal count, as well as #3 for global and US-announced deals – principals by deal count. Bloomberg also ranked Cooley #2 for US mid-market deals and private equity deals by deal count.*
• Mergermarket, which ranked the firm #4 on its US league table by deal count and #5 on its global league table by deal count, as well as #3 for US private equity buyouts, #4 for global private equity buyouts by deal count, #6 for US private equity exits by value, and #5 for US private equity exits by deal count.
• LSEG, which ranked the firm #5 on its US league table for completed deals by deal count and #6 on its global league table for completed deals by deal count.

To earn these rankings, Cooley handled transactions across a diverse range of industries while maintaining its top position in life sciences and technology – including market-leading deals in artificial intelligence (AI).

In the first half of 2024, Cooley advised:

• Risk, compliance and governance platform AuditBoard on its $3 billion acquisition by Hg
• AI-powered and data-driven cloud security company Lacework on its acquisition by Fortinet
• Oncology-focused biopharmaceutical company Nuvation Bio on its acquisition of AnHeart Therapeutics
• Cyber-risk exposure management company Tenable on its acquisition of Eureka Security
• Clinical-stage oncology biotech firm ProfoundBio on its $1.8 billion acquisition by Genmab
• Critical event management solutions company Everbridge on its $1.8 billion take-private acquisition by Thoma Bravo
• Distilled spirts company Sazerac on its acquisition of BuzzBallz
• Clinical-stage biotech company Amolyt Pharma on its $1.05 billion acquisition by AstraZeneca
• AI-based software company Freshworks on its acquisition of Device42
• AI-powered talent solutions company HiredScore on its acquisition by Workday
• Third-party lottery app Jackpocket on its $750 million acquisition by DraftKings
• Global gaming products supplier PlayAGS on its $1.1 billion take-private acquisition by Brightstar Capital Partners
• Venture capital firm Accel regarding its interests in Squarespace’s $6.9 billion take-private acquisition
• AI-focused tech consultancy firm Nuvalence on its acquisition by EY
• Social media management company Hootsuite on its acquisition of Talkwalker, an AI-powered social listening solution
• Clinical-stage biotech company Radionetics Oncology on its $140 million collaboration agreement with Eli Lilly, from which the company obtained the exclusive right to acquire Radionetics for $1 billion

In the last five years, Cooley’s world-class transactional team has worked on 1,540+ M&A deals for an aggregate value of more than $745 billion – guiding top public and private companies, financial advisers, and private equity sponsors in some of the market’s largest and most complex transactions. The M&A and Private Equity groups includes 180+ practitioners in major business and technology centers worldwide, representing all categories of participants in transactions.

* The Bloomberg platform data has not itself been published by Bloomberg.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has more than 1,300 lawyers across 19 offices in the United States, Asia and Europe, and a total workforce of nearly 3,000.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.